We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Humana Inc. (HUM - Free Report) is one of the largest health care plan providers in the United States.
At present Humana’s core operations include the provision of health insurance benefits under Health Maintenance Organization (HMO), Private Fee-For-Service (PFFS), and Preferred Provider Organization (PPO) plans.
The company also provides other benefits with specialty products including dental, vision, and other supplementary benefits. Humana capitalizes on its established Accountable Care arrangement to provide its Medicare Advantage (MA) members with quality care at an affordable price.
Humana has a solid history when it comes to earnings as the stock has beaten estimates in all of the last four quarters, making for an average surprise of 6.6%.
Revenue: Revenues miss our estimates. Our consensus called for revenues of $13,394 million, and the company reported revenues of $13,057 million.
Key Stats to Note:
Benefit ratio deteriorated 90 basis points to 82.4% in the quarter. Operating cost ratio improved 130 basis points to 10.7%.
Operating cash flow totaled $2.8 billion, up 89% over the prior year quarter.
Check back later for our full write up on this HUM earnings report later!
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Image: Bigstock
Humana's (HUM) Q3 Earnings Beat, Revenues Miss
Humana Inc. (HUM - Free Report) is one of the largest health care plan providers in the United States.
At present Humana’s core operations include the provision of health insurance benefits under Health Maintenance Organization (HMO), Private Fee-For-Service (PFFS), and Preferred Provider Organization (PPO) plans.
The company also provides other benefits with specialty products including dental, vision, and other supplementary benefits. Humana capitalizes on its established Accountable Care arrangement to provide its Medicare Advantage (MA) members with quality care at an affordable price.
Humana has a solid history when it comes to earnings as the stock has beaten estimates in all of the last four quarters, making for an average surprise of 6.6%.
Currently, Humana has a Zacks Rank #3 (Hold), but that could definitely change following its earnings report which was just released. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
We have highlighted some of the key stats from this just-revealed announcement below:
Earnings: Humana surpassed our earnings estimate. Our consensus called for EPS of $3.27, and the company reported EPS of $3.39.
Humana Inc. Price and EPS Surprise
Humana Inc. Price and EPS Surprise | Humana Inc. Quote
Revenue: Revenues miss our estimates. Our consensus called for revenues of $13,394 million, and the company reported revenues of $13,057 million.
Key Stats to Note:
Benefit ratio deteriorated 90 basis points to 82.4% in the quarter. Operating cost ratio improved 130 basis points to 10.7%.
Operating cash flow totaled $2.8 billion, up 89% over the prior year quarter.
Check back later for our full write up on this HUM earnings report later!
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>